Erratum: Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation (Diseases of the Colon and Rectum DOI: 10.1007/s10350-006-0842-5);Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation

Diseases of the Colon and Rectum

Volumn 50, Issue 8, 2007, Pages 1169-1181

  Yamashita, Kaname ^a   Ougolkov, Andrei V ^a,b   Nakazato, Hiroaki ^c   Ito, Katsuki ^c   Ohashi, Yasuo ^c   Kitakata, Hidekazu ^a   Yasumoto, Kazuo ^a   Omote, Kazuhiko ^a   Mai, Masayoshi ^a   Takahashi, Yutaka ^a   Minamoto, Toshinari ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b MAYO CLINIC   (United States)

^c Study Group of Colon Cancer Immunochemotherapy with PSK and 5 FU (CIP)   (Japan)

Author keywords

Colon cancer; Immunochemotherapy; Nuclear factor kappaB; Protein bound polysaccharide K; catenin

Indexed keywords

BETA CATENIN; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRESTIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIVARIATE ANALYSIS; ONCOGENE; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BINDING; RECURRENCE RISK; SURVIVAL RATE; TUMOR; TUMOR CELL;

EID: 34447641405     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-007-0291-9     Document Type: Erratum

References (43)

1. R Midgley D Kerr 1999 Colorectal cancer Lancet 353 391 399
2. JS Wu VW Fazio 2000 Colon cancer Dis Colon Rectum 43 1473 1486
3. A Jemal A Thomas T Murray M Thun 2002 Cancer statistics, 2002 CA Cancer J Clin 52 23 47
4. RS Midgley DJ Kerr 2003 Immunotherapy for colorectal cancer Expert Rev Anticancer Ther 3 63 78
5. C Ratto L Sofo M Ippoliti M Merico GB Doglietto F Crucitti 1998 Prognostic factors in colorectal cancer. Literature review for clinical application Dis Colon Rectum 41 1033 1049
6. H Nakazato A Koike S Saji N Ogawa J Sakamoto 1994 Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer Lancet 343 1122 1126
7. T Mitomi S Tsuchiya N Iijima 1992 Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer Dis Colon Rectum 35 123 130
8. S Ohwada T Ikeya T Yokomori 2004 Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study Br J Cancer 90 1003 1010
9. K Ito H Nakazato A Koike 2004 Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up Int J Colorectal Dis 19 157 164
10. M Fisher LX Yang 2002 Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy Anticancer Res 22 1737 1754
11. S Tsujitani Y Kakeji H Orita 1992 Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer Anticancer Res 12 645 648
12. J Sakamoto A Koike S Saji S Teramukai Y Ohashi H Nakazato 1992 Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK Surg Today 22 530 536
13. K Ogoshi Y Kondoh T Tajima T Mitomi 1992 Glycosidically bound sialic acid levels as a predictive marker of postoperative adjuvant therapy in gastric cancer Cancer Immunol Immunother 35 175 180
14. T Toge Y Yamaguchi 2000 Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count Oncol Rep 7 1157 1161
15. DC Chung 2000 The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis Gastroenterology 119 854 865
16. JR Jass VL Whitehall J Young BA Leggett 2002 Emerging concepts in colorectal neoplasia Gastroenterology 123 862 876
17. P Polakis 1999 The oncogenic activation of beta-catenin Curr Opin Genet Dev 9 15 21
18. NA Wong M Pignatelli 2002 β-Catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160 389 401
19. T Minamoto A Ougolkov M Mai 2002 Detection of oncogenes in the diagnosis of cancer with active oncogenic signaling Expert Rev Mol Diagn 2 565 575
20. A Kikuchi 2003 Tumor formation by genetic mutations in the components of the Wnt signaling pathway Cancer Sci 94 225 229
21. AV Ougolkov K Yamashita M Mai T Minamoto 2002 Oncogenic β-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer Gastroenterology 122 60 71
22. B Zhang A Ougolkov K Yamashita Y Takahashi M Mai T Minamoto 2003 β-Catenin and ras oncogenes detect most human colorectal cancer Clin Cancer Res 9 3073 3079
23. VS Spiegelman TJ Slaga M Pagano T Minamoto Z Ronai S Fuchs 2000 Wnt/β-catenin signaling includes the expression and activity of βTrCP ubiquitin ligase receptor Mol Cell 5 877 882
24. A Ougolkov B Zhang K Yamashita 2004 Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer J Natl Cancer Inst 96 1161 1170
25. H Zhang T Morisaki C Nakahara 2003 PSK-mediated NF-κB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1 Oncogene 22 2088 2096
26. Japanese Society for Cancer of the Colon and Rectum 1997 Japanese classification of colorectal carcinoma. First English ed. Kanehara & Co, Ltd Tokyo
27. World Health Organization 1988 International histological classification of tumours. 2nd ed. Geneva: World Health Organization, 1969-1981 Springer-Verlag Berlin
28. LH Sobin Ch Wittekind 1997 TNM classification of malignant tumors 5 John Wiley & Sons New York 66 69
29. IM Verma J Stevenson 1997 IkappaB kinase: beginning, not the end Proc Natl Acad Sci USA 94 11758 11760
30. D Collet 1994 Modelling survival data in medical research Chapman & Hall London
31. PG Johnston ER Fisher HE Rockette 1994 The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer J Clin Oncol 12 2640 2647
32. CG Leichman HJ Lenz L Leichman 1997 Quantification of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin J Clin Oncol 15 3223 3229
33. C Aschele D Debernardis S Casazza 1999 Immunohistochemical quantification of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy J Clin Oncol 17 1760 1770
34. J Sakamoto H Hamashima H Suzuki (the CIP Genetic Marker Committee) 2003 Thymidylate synthase expression as a predictor of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant immunochemotherapy clinical trial Oncol Rep 10 1081 1090
35. K Hirose CO Zachariae JJ Oppenheim K Matsushima 1990 Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells Lymphokine Res 9 475 483
36. F Vánky P Wang E Klein 1992 The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells Cancer Immunol Immunother 35 193 198
37. I Algarra A Collado F Garrido 1997 Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones J Exp Clin Cancer Res 16 373 380
38. M Kanazawa Y Mori K Yoshihara 2004 Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes Immunol Lett 91 229 238
39. M Harada K Matsunaga Y Oguchi 1997 Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice Int J Cancer 70 362 372
40. K Matsunaga A Hosokawa M Oohara N Sugita M Harada K Nomoto 1998 Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-β Immunopharmacology 40 219 230
41. C Iguchi Y Nio H Takeda 2001 Plant polysaccharide PSK: cytostatic effects on growth and invasion; modulating effect on the expression of HLA and adhesion molecules on human gastric and colonic tumor cell surface Anticancer Res 21 1007 1013
42. E Yefenof I Gafanovitch E Oron M Bar E Klein 1995 Prophylactic intervention in radiation-leukemia- virus-induced murine lymphoma by the biological response modifier polysaccharide K Cancer Immunol Immunother 41 389 396
43. SC Wong SF Lo MT Cheung 2004 Quantification of plasma β-catenin mRNA in colorectal cancer and adenoma patients Clin Cancer Res 10 1613 1617